Send to

Choose Destination
Apoptosis. 2003 Jan;8(1):45-53.

Differential regulation of cell survival by CD40.

Author information

Cancer Research UK Oncology Unit, Cancer Sciences Division, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD, UK.


The CD40 cell surface receptor is required for normal function of the immune system and is a positive regulator of cell survival for normal B-lymphocytes. However, there is evidence to support both pro- and anti-apoptotic functions for CD40 in malignant B-cells and epithelial cancers. There is increasing interest in the potential of CD40 activating agents as novel therapies for cancer and it is essential to understand the differential response of malignant cells, to inform the design of trials. Here we review the current understanding of differential responses to CD40 activation and apoptosis controlling proteins regulated by CD40 that might account for these effects.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center